Gilead Sciences, Inc. (GILD)
143.70
-1.11
(-0.77%)
USD |
NASDAQ |
Sep 11, 14:43
Gilead Sciences Gross Profit (TTM) : 24.33B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.33B |
| March 31, 2026 | 23.65B |
| December 31, 2025 | 23.22B |
| September 30, 2025 | 22.86B |
| June 30, 2025 | 22.60B |
| March 31, 2025 | 22.45B |
| December 31, 2024 | 22.48B |
| September 30, 2024 | 22.04B |
| June 30, 2024 | 21.56B |
| March 31, 2024 | 21.30B |
| December 31, 2023 | 21.09B |
| September 30, 2023 | 21.88B |
| June 30, 2023 | 22.01B |
| March 31, 2023 | 21.64B |
| December 31, 2022 | 21.86B |
| September 30, 2022 | 20.65B |
| June 30, 2022 | 21.27B |
| March 31, 2022 | 21.34B |
| December 31, 2021 | 21.29B |
| September 30, 2021 | 22.25B |
| June 30, 2021 | 21.46B |
| March 31, 2021 | 20.67B |
| December 31, 2020 | 20.13B |
| September 30, 2020 | 18.20B |
| June 30, 2020 | 17.32B |
| Date | Value |
|---|---|
| March 31, 2020 | 17.90B |
| December 31, 2019 | 17.65B |
| September 30, 2019 | 17.69B |
| June 30, 2019 | 17.67B |
| March 31, 2019 | 17.52B |
| December 31, 2018 | 17.36B |
| September 30, 2018 | 17.84B |
| June 30, 2018 | 18.79B |
| March 31, 2018 | 20.26B |
| December 31, 2017 | 21.60B |
| September 30, 2017 | 23.11B |
| June 30, 2017 | 23.98B |
| March 31, 2017 | 24.90B |
| December 31, 2016 | 25.92B |
| September 30, 2016 | 27.00B |
| June 30, 2016 | 27.72B |
| March 31, 2016 | 27.86B |
| December 31, 2015 | 27.92B |
| September 30, 2015 | 26.82B |
| June 30, 2015 | 24.79B |
| March 31, 2015 | 23.35B |
| December 31, 2014 | 20.99B |
| September 30, 2014 | 17.07B |
| June 30, 2014 | 14.12B |
| March 31, 2014 | 10.59B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 10.94B |
| AbbVie, Inc. | 45.98B |
| Regeneron Pharmaceuticals, Inc. | 12.65B |
| Amgen, Inc. | 27.78B |
| Biogen, Inc. | 6.211B |